Related references
Note: Only part of the references are listed.Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
Gwen Lomberk et al.
NATURE COMMUNICATIONS (2018)
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
Xiaorong Gu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition
Francis O. Enane et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
Remy Nicolle et al.
CELL REPORTS (2017)
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling
Olga Zaytseva et al.
GENES (2017)
Germline Stem Cell Activity Is Sustained by SALL4-Dependent Silencing of Distinct Tumor Suppressor Genes
Ai-Leen Chan et al.
STEM CELL REPORTS (2017)
Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
Hannah K. Long et al.
CELL (2016)
Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration
Xuxu Sun et al.
CELL STEM CELL (2016)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo et al.
CELL REPORTS (2016)
An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development
Shingo Komura et al.
STEM CELL REPORTS (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
Meng Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal Tumors
Ariel L. Furst et al.
CHEMISTRY & BIOLOGY (2015)
Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans
Lisa M. Abegglen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes
Yogen Saunthararajah et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage
Ori Bar-Nur et al.
NATURE BIOTECHNOLOGY (2015)
Reversible Inhibitors of LSD1 as Therapeutic Agents in Acute Myeloid Leukemia: Clinical Significance and Progress to Date
Daniel P. Mould et al.
MEDICINAL RESEARCH REVIEWS (2015)
Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages
Ke Li et al.
CELL STEM CELL (2014)
Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy
Xiaorong Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mouse liver repopulation with hepatocytes generated from human fibroblasts
Saiyong Zhu et al.
NATURE (2014)
MYC and the Control of DNA Replication
David Dominguez-Sola et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
Reena Shakya et al.
CANCER RESEARCH (2013)
The transcription factor GATA4 is required for follicular development and normal ovarian function
Evgeni Efimenko et al.
DEVELOPMENTAL BIOLOGY (2013)
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Laura Soucek et al.
GENES & DEVELOPMENT (2013)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein
D. Guan et al.
ONCOGENE (2013)
Networks of bZIP Protein-Protein Interactions Diversified Over a Billion Years of Evolution
Aaron W. Reinke et al.
SCIENCE (2013)
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine
Donald Lavelle et al.
BLOOD (2012)
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)
Nelli Bejanyan et al.
CANCER (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Genetically Engineered Mouse Models of Pancreatic Cancer
Christoph Benedikt Westphalen et al.
CANCER JOURNAL (2012)
Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo
Oscar Alcazar et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis
Shouhong Xuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
GATA4 and GATA6 control mouse pancreas organogenesis
Manuel Carrasco et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Molecular Roadblocks for Cellular Reprogramming
Thomas Vierbuchen et al.
MOLECULAR CELL (2012)
CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors
S. Negrotto et al.
LEUKEMIA (2012)
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Tino Schenk et al.
NATURE MEDICINE (2012)
Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
Annika Jogi et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
Quteba Ebrahem et al.
ONCOTARGET (2012)
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031
V. J. Picozzi et al.
ANNALS OF ONCOLOGY (2011)
Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Independent prognostic variables in acute myeloid leukaemia
Matthew L. Smith et al.
BLOOD REVIEWS (2011)
Noncytotoxic Differentiation Treatment of Renal Cell Cancer
Soledad Negrotto et al.
CANCER RESEARCH (2011)
Subunit Organization of the Human INO80 Chromatin Remodeling Complex AN EVOLUTIONARILY CONSERVED CORE COMPLEX CATALYZES ATP-DEPENDENT NUCLEOSOME REMODELING
Lu Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Premetazoan Ancestry of the Myc-Max Network
Susan L. Young et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia
K. P. Ng et al.
LEUKEMIA (2011)
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy
Jem A. Efe et al.
NATURE CELL BIOLOGY (2011)
Direct reprogramming of mouse fibroblasts to neural progenitors
Janghwan Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Alina Molchadsky et al.
CARCINOGENESIS (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
The ups and downs of Myc biology
Laura Soucek et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex
Linsey Reavie et al.
NATURE IMMUNOLOGY (2010)
Global Chromatin Architecture Reflects Pluripotency and Lineage Commitment in the Early Mouse Embryo
Kashif Ahmed et al.
PLOS ONE (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
p/CAF modulates the activity of the transcription factor p48/Ptf1a involved in pancreatic acinar differentiation
Annie Rodolosse et al.
BIOCHEMICAL JOURNAL (2009)
Foxl2 functions in sex determination and histogenesis throughout mouse ovary development
Jose Elias Garcia-Ortiz et al.
BMC DEVELOPMENTAL BIOLOGY (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors
Kirsty Jensen et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation
Laura M. Green et al.
NUCLEIC ACIDS RESEARCH (2009)
Estimating Dormant and Active Hematopoietic Stem Cell Kinetics through Extensive Modeling of Bromodeoxyuridine Label-Retaining Cell Dynamics
Richard C. van der Wath et al.
PLOS ONE (2009)
Conditional Inactivation of Brca1, p53 and Rb in Mouse Ovaries Results in the Development of Leiomyosarcomas
Katherine V. Clark-Knowles et al.
PLOS ONE (2009)
Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc Activity
Elisa Laurenti et al.
CELL STEM CELL (2008)
Myc Inhibits p27-Induced Erythroid Differentiation of Leukemia Cells by Repressing Erythroid Master Genes without Reversing p27-Mediated Cell Cycle Arrest
Juan C. Acosta et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
Hongwu Zheng et al.
NATURE (2008)
The genetics of the p53 pathway, apoptosis and cancer therapy
Alexei Vazquez et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs:: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks
Luis F. Z. Batista et al.
CANCER RESEARCH (2007)
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
Takashi Kumagai et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property
Jens M. Nygren et al.
JOURNAL OF IMMUNOLOGY (2006)
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
M Hermisson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Chromatin remodelling: the industrial revolution of DNA around histones
Anjanabha Saha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Antimitogenic and chernosensitizing effects of the methylation inhibitor zebularine in ovarian cancer
C Balch et al.
MOLECULAR CANCER THERAPEUTICS (2005)
HNF4α reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma
B Lucas et al.
ONCOGENE (2005)
Taking the Myc is bad for Theileria
F Dessauge et al.
TRENDS IN PARASITOLOGY (2005)
The initiation of liver development is dependent on Foxa transcription factors
CS Lee et al.
NATURE (2005)
C-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes
G Dessauge et al.
ONCOGENE (2005)
Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification
T Hosaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
A Wilson et al.
GENES & DEVELOPMENT (2004)
Molecular pathogenesis of astrocytic tumours
K Ichimura et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
CM Shachaf et al.
NATURE (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2′-deoxycytidine
D Cecconi et al.
ELECTROPHORESIS (2003)
Proliferation kinetics of subpopulations of human marrow cells determined by quantifying in vivo incorporation of [2H2]-glucose into DNA of S-phase cells
GN Schwartz et al.
BLOOD (2003)
A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR
S Ramaswamy et al.
CANCER CELL (2002)
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny
I Arnold et al.
CURRENT BIOLOGY (2001)
Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro
KI Lin et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
A chromatin remodelling complex involved in transcription and DNA processing
XT Shen et al.
NATURE (2000)
The chrome domain protein Chd1p from budding yeast is an ATP-dependent chromatin-modifying factor
HG Tran et al.
EMBO JOURNAL (2000)
Share Paper
